0.33 (0.837%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Neutral
Website
TG Therapeutics, Inc.
Telephone
1.212.554.4484
Address
Suite 475, 3020 Carrington Mill Boulevard, Morrisville, NC 27560
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 25.28 - 44.65
Trade Value (12mth)
US$16,292,886.00
1 week
-0.18%
1 month
8.68%
YTD
34.67%
1 year
15.29%
All time high
7031.25
EPS 3 yr Growth
-311.60%
EBITDA Margin
20.30%
Operating Cashflow
-$25m
Free Cash Flow Return
-3.60%
ROIC
65.00%
Interest Coverage
4.70
Quick Ratio
3.30
Shares Outstanding (Fully Diluted)
160m
HALO Sector
Healthcare
Next Company Report Date
02-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 07 May 26 | |
| 07 May 26 | |
| 06 May 26 | |
| 06 May 26 | |
| 28 February 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | 0.09 | 0.16 | 3.1 | | | | ||
EPS (Fully Diluted) | $ | | | | | 0.09 | 0.15 | 2.77 | | | | ||
Growth | % | | | | | 106.1 | 80.2 | 1,825.8 | | | | ||
PE | X | | | | | 200.2 | 206.4 | 10.8 | | | | ||
EV/EBITDA | X | | | | | 114.9 | 112.8 | 39.2 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
